▮ Slide Shows

▮ Entertainment

Top Stories
Game of Thrones
▮ Music news
- Pop
- Rock
- Classic Rock
- Rap/Hip-Hop
- Country
- Alternative
- Oldies
- All Genre

▮ Content Licensing

▮ Premium NEW

▮ More

Wall Street Events

Leggett & Platt Q4 21 Earnings Conference Call At 8:30 AM ET

By RTTNews Staff Writer ✉ | Published: 2/8/2022 7:30 AM ET

Leggett & Platt Inc. (LEG) will host a conference call at 8:30 AM ET on February 8, 2022, to discuss Q4 21 earnings results.

To access the live webcast, log on to http://www.leggett.com

To listen to the call, dial 201-689-8341.

For comments and feedback contact: editorial@rttnews.com

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In June 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In March 2022

Biotech Stocks Facing FDA Decision In February 2022 non small cell lung cancer chemotherapy

Biotech Stocks Facing FDA Decision In February 2022

Latest Updates on COVID-19

U.S. Covid Cases Fall 18% In A Fortnight

U.S. Reports 128K New Covid Cases, 464 Deaths

U.S. Reports 10,263 New Covid Cases, 11 Deaths

Roche Unveils Elecsys IGRA SARS-CoV-2 Test In Countries That Accept CE Mark

CDC No Longer Recommends Quarantine, Screening For COVID-19

Read More

COVID-19: Drugs in Development

RELATED NEWS

Leggett & Platt Q2 22 Earnings Conference Call At 8:30 AM ET

Leggett & Platt Lowers FY22 Outlook

Leggett & Platt Inc. Q2 Profit Drops, Inline With Estimates

Follow RTT

Editor's Pick
Most Read
Most Emailed

Delta To Resume Flights From Los Angeles To Tokyo

Apple Sets Sept. 5 Deadline For Return To Office

Walmart Q2 Profit Up 20%; Revenues Top Estimates

Janus International Reports Profit In Q2

Over 2 Mln MamaRoo, RockaRoo Infant Swings, Rockers Recalled; Death Reported

Walmart+ Members To Get Free Paramount+ Subscription

Fifth Season Recalls Crunchy Sesame Salad Kits

Tesla Produced Over 3 Mln Vehicles, 1 Mln In China: Elon Musk

King's Hawaiian Recalls Pretzel Buns, Bites

Henkel H1 Profit Down, Backs FY22 Adj. Earnings View; Lifts Sales Forecast

Home Run Inn Recalls Frozen Meat Pizza

CDC No Longer Recommends Quarantine, Screening For COVID-19

Lyons Magnus Expands Recall Of Nutritional And Beverage Products

888 Holdings H1 Earnings Fall

Toast Up As Q2 Results Improve; Annual Sales Outlook Raised

UNITY Reports Positive Proof-of-concept Data With UBX1325 In Patients With Diabetic Macular Edema

Deutsche Telekom Lifts FY22 View Despite Weak Q2 Profit; Stock Up

AZN : Enhertu Approved In U.S. As First HER2 Directed Therapy For HER2 Mutant Metastatic NSCLC

Disney+ With No Ads To Now Come At $3 Premium Per Month

Johnson & Johnson To Discontinue Talc-based Baby Powder

Pfizer: Phase 3 Study Of 20-Valent Pneumococcal Conjugate Vaccine Posts Positive Results In Infants

PLx Pharma Q2 Loss Top Estimates, But Revenues Miss; Stock Down 15%

South Korea Approves Novavax's Nuvaxovid COVID-19 Vaccine For Use In Adolescents

Resmed Inc Q4 sales increase

Delta To Resume Flights From Los Angeles To Tokyo

Elbit Systems Q2 Adj. Net Income Declines

U.S. Postal Service To Raise Prices Temporarily For Holiday Season

Horizon Enters Option Agreement With Q32 Bio To Advance ADX-914 For Autoimmune Diseases

Humana To Acquire Substantially All Of The Assets Of Inclusa For Undisclosed Terms

Blend Labs, Inc Q2 Earnings Summary

Aegon Q2 Operating Result Declines

Walmart Q2 Profit Up 20%; Revenues Top Estimates

Pfizer: Phase 3 Study Of 20-Valent Pneumococcal Conjugate Vaccine Posts Positive Results In Infants

Cerevel Prices Public Offering Of Common Stock, And Concurrent Private Offering Of Senior Notes

Uber Teams With Office Depot For Delivery Of Office, School Essentials

King's Hawaiian Recalls Pretzel Buns, Bites